Page last updated: 2024-10-25

debrisoquin and Anesthesia

debrisoquin has been researched along with Anesthesia in 2 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.

Research Excerpts

ExcerptRelevanceReference
"Debrisoquin was administered twice daily at the dose of 2."1.26The cardiovascular effects of the antihypertensive drug debrisoquin: A contribution to the pharmacology of chronic treatment. II. Eight-week administration to dogs. ( Cavero, I; Gerold, M; Haeusler, G; Saner, A, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerold, M1
Cavero, I1
Saner, A1
Haeusler, G1
Antonaccio, MJ1

Other Studies

2 other studies available for debrisoquin and Anesthesia

ArticleYear
The cardiovascular effects of the antihypertensive drug debrisoquin: A contribution to the pharmacology of chronic treatment. II. Eight-week administration to dogs.
    The Journal of pharmacology and experimental therapeutics, 1978, Volume: 206, Issue:3

    Topics: Anesthesia; Animals; Blood Pressure; Body Weight; Cardiovascular System; Debrisoquin; Dogs; Drug Tol

1978
Paradoxical vagal tachycardia in ganglion-blocked anesthetized dogs.
    European journal of pharmacology, 1974, Volume: 28, Issue:1

    Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Atropine; Blood Pressure; Bretylium Compounds; Chl

1974